Free Trial

Pacira BioSciences (PCRX) Earnings Date, Estimates & Call Transcripts

Pacira BioSciences logo
$22.66 -0.49 (-2.12%)
As of 12:41 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Pacira BioSciences Earnings Summary

Pacira BioSciences announced Q1 2026 earnings on April 30, 2026, reporting an EPS of $0.60, which missed the consensus estimate of $0.61 by $0.01. Quarterly revenue rose 5.0% year-over-year to $177.38 million, above the consensus estimate of $171.80 million. With a trailing EPS of $0.12 and a P/E Ratio of 188.55, Pacira BioSciences' earnings are expected to grow 27.03% next year, from $1.85 to $2.35 per share.

Latest Q1
Earnings Date
Apr. 30Estimated
Consensus EPS
(Apr. 30)
$0.61
Actual EPS
(Apr. 30)
$0.60 Missed By -$0.01
Actual Revenue
(Apr. 30)
$177.38M

Q1 2026 Earnings Resources

Get Pacira BioSciences Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Pacira BioSciences and other key companies, straight to your inbox.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Estimated and Actual Earnings Data

PCRX Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

PCRX Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Pacira BioSciences Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateRevenue EstimateCompany Revenue Guidance
Q1 20262$0.46$0.65$0.56
Q2 20262$0.27$0.69$0.48
Q3 20262$0.62$0.67$0.65
Q4 20262$0.65$0.65$0.65
FY 2026 8 $2.00 $2.66 $2.33
Q1 20272$0.21$0.59$0.40
Q2 20272$0.37$0.61$0.49
Q3 20271$0.41$0.41$0.41
Q4 20271$0.49$0.49$0.49

Pacira BioSciences Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
4/30/2026Q1 2026$0.61$0.60 -$0.01$0.07$171.80M$177.38M
2/26/2026Q4 2025$0.85$0.57 -$0.28$0.04$201.93M$196.87M
11/6/2025Q3 2025$0.65$0.70+$0.05$0.12$182.86M$179.52M
8/5/2025Q2 2025$0.73$0.74+$0.01-$0.11$183.11M$181.10M
11/6/2024Q3 2024$0.50$0.53+$0.03$4.17$169.26M$167.72M
7/30/2024Q2 2024$0.53$0.64+$0.11$0.89$173.31M$178.02M

Data powered by Fiscal.ai.

Pacira BioSciences Earnings - Frequently Asked Questions

Pacira BioSciences (NASDAQ:PCRX) last announced its quarterly earning data on Thursday, April 30, 2026. Learn more on PCRX's earnings history.

Pacira BioSciences updated its FY 2026 earnings guidance on Thursday, April, 30th. The company issued revenue guidance of $745.0 million-$770.0 million, compared to the consensus revenue estimate of $761.5 million.

In the previous quarter, Pacira BioSciences (NASDAQ:PCRX) missed the analysts' consensus estimate of $0.61 by $0.01 with a reported earnings per share (EPS) of $0.60. Learn more on analysts' earnings estimate vs. PCRX's actual earnings.

The conference call for Pacira BioSciences' latest earnings report can be listened to online.
Listen to Conference Call

The conference call transcript for Pacira BioSciences' latest earnings report can be read online.
Read Transcript

Pacira BioSciences (NASDAQ:PCRX) has a recorded annual revenue of $734.86 million.

Pacira BioSciences (NASDAQ:PCRX) has a recorded net income of $7.03 million. PCRX has generated $0.12 earnings per share over the last four quarters.

Pacira BioSciences (NASDAQ:PCRX) has a trailing price-to-earnings ratio of 192.93 and a forward price-to-earnings ratio of 12.51.

Pacira BioSciences' earnings are expected to grow from $1.85 per share to $2.35 per share in the next year, which is a 27.03% increase.


This page (NASDAQ:PCRX) was last updated on 5/11/2026 by MarketBeat.com Staff.
From Our Partners